Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	benzodiazepine receptor binding	RIMBP3 RIMBP3C RIMBP3B	5.18e-06	5	162	3	GO:0030156
GeneOntologyMolecularFunction	secondary active transmembrane transporter activity	SLC24A5 SLC9A9 SLC28A3 SLC10A3 SLC18B1 SLC1A5 SLC5A5 SLC46A3 SLC45A3 SLC5A8 SLC25A19	3.11e-05	296	162	11	GO:0015291
GeneOntologyMolecularFunction	symporter activity	SLC24A5 SLC28A3 SLC10A3 SLC1A5 SLC5A5 SLC46A3 SLC45A3 SLC5A8	3.13e-05	150	162	8	GO:0015293
GeneOntologyMolecularFunction	transcription factor binding	BDP1 MAGEA11 TBX3 ZBTB16 WWP2 PCLO DAZAP2 GBX2 SKI IFI27 PIAS2 HDAC7 DDIT3 MLXIPL MTOR TAF4 BSN EBF4	4.17e-05	753	162	18	GO:0008134
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	FLI1 TBX3 ZBTB16 ESRRA GBX2 EBF1 MLXIP RREB1 DDIT3 PRDM2 MLXIPL ELF4 ELK3 NOTCH1 EBF4	5.33e-05	560	162	15	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	FLI1 TBX3 ZBTB16 ESRRA GBX2 EBF1 MLXIP RREB1 DDIT3 PRDM2 MLXIPL ELF4 ELK3 NOTCH1 EBF4	6.01e-05	566	162	15	GO:0001216
GeneOntologyMolecularFunction	TFIIIC-class transcription factor complex binding	BDP1 MTOR	6.54e-05	2	162	2	GO:0001156
GeneOntologyMolecularFunction	RNA polymerase III general transcription initiation factor binding	BDP1 MTOR	3.88e-04	4	162	2	GO:0001025
GeneOntologyMolecularFunction	sodium ion transmembrane transporter activity	SLC24A5 SLC9A9 PKD2L1 SLC28A3 SLC10A3 SLC5A5 SLC5A8	5.01e-04	171	162	7	GO:0015081
GeneOntologyMolecularFunction	active transmembrane transporter activity	SLC24A5 SLC9A9 ABCC11 SLC28A3 SLC10A3 SLC18B1 SLC1A5 SLC5A5 SLC46A3 SLC45A3 SLC5A8 SLC25A19	5.33e-04	477	162	12	GO:0022804
GeneOntologyMolecularFunction	transporter activity	SLC24A5 PITPNM2 SLC9A9 CEACAM7 PKD2L1 ABCC11 SLC28A3 SLC10A3 ATG2A PKD1L2 SLC18B1 SLC1A5 RHD SLC5A5 MFSD14A SLC46A3 SLC7A3 MFSD14B SLC45A3 SLC5A8 SLC25A19 SLC14A2	7.49e-04	1289	162	22	GO:0005215
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	MAGEA11 TBX3 WWP2 DAZAP2 GBX2 SKI IFI27 PIAS2 HDAC7 DDIT3 MLXIPL TAF4 EBF4	9.48e-04	582	162	13	GO:0140297
Domain	Znf_piccolo	PCLO BSN	7.48e-05	2	162	2	IPR008899
Domain	zf-piccolo	PCLO BSN	7.48e-05	2	162	2	PF05715
Domain	COE	EBF1 EBF4	4.44e-04	4	162	2	PS01345
Domain	Transcription_factor_COE	EBF1 EBF4	4.44e-04	4	162	2	IPR003523
Domain	COE_HLH	EBF1 EBF4	4.44e-04	4	162	2	IPR032201
Domain	COE_DBD	EBF1 EBF4	4.44e-04	4	162	2	IPR032200
Domain	Transcription_factor_COE_CS	EBF1 EBF4	4.44e-04	4	162	2	IPR018350
Domain	COE1_HLH	EBF1 EBF4	4.44e-04	4	162	2	PF16423
Domain	COE1_DBD	EBF1 EBF4	4.44e-04	4	162	2	PF16422
Domain	MFS_1	SLC18B1 MFSD14A SLC46A3 MFSD14B SLC45A3	5.51e-04	77	162	5	PF07690
Domain	MFS	SLC18B1 MFSD14A SLC46A3 MFSD14B SLC45A3	5.51e-04	77	162	5	IPR011701
Pubmed	A census of human transcription factors: function, expression and evolution.	FLI1 TBX3 ESRRA MIER3 KIAA1549 GBX2 EBF1 MLXIP RREB1 SKI DDIT3 PRDM2 HIVEP3 MLXIPL ZFHX4 UNKL ELF4 ELK3 CAMTA1 EBF4	1.25e-08	908	164	20	19274049
Pubmed	Interaction network of human early embryonic transcription factors.	FLI1 TBX3 RREB1 SKI PIAS2 EMSY PRDM2 ZNF462 ZFHX4 NFRKB TAF5L TAF4 BAHCC1	1.41e-08	351	164	13	38297188
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PITPNM2 BDP1 ZBTB16 MAP2 ATXN7L1 PPFIA2 TBC1D5 WWP2 SKI MAP3K12 TMCO4 ZNF462 HIVEP3 ARHGAP6 INTS6 TMEM242 PTPRG VPS35L ELK3 TAF4 CAMTA1 MBD5 DAGLA DOP1A PDZD2	3.63e-08	1489	164	25	28611215
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PITPNM2 SYNRG LRRC24 LAMB3 GBX2 SLC10A3 ATG2A MLXIP HDAC7 SLC1A5 HIVEP3 ARHGEF40 MTMR14 SLC45A3 MTOR UNKL FGFR2 MBD5 NOTCH1 BAHCC1	2.98e-07	1105	164	20	35748872
Pubmed	RIM-BP3 is a manchette-associated protein essential for spermiogenesis.	RIMBP3 RIMBP3C RIMBP3B	4.10e-07	4	164	3	19091768
Pubmed	Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.	ASAH2 MLXIP RREB1 HDAC7 MLXIPL FGFR2	7.89e-07	67	164	6	23263486
Pubmed	MondoA-Mlx transcriptional activity is limited by mTOR-MondoA interaction.	MLXIP MLXIPL MTOR	1.02e-06	5	164	3	25332233
Pubmed	Structure and evolution of RIM-BP genes: identification of a novel family member.	RIMBP3 RIMBP3C RIMBP3B	1.02e-06	5	164	3	17855024
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	FLI1 DDX31 ZNF280D INCENP RREB1 PIAS2 EMSY PRDM2 KIF20A ZNF462 NFRKB ZSCAN18 CDYL TAF4	1.28e-06	608	164	14	36089195
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SYNRG ZBTB16 ARHGEF28 CAMKK1 MAP2 TBC1D5 WWP2 KCTD8 MLXIP HDAC7 SLC1A5 MLXIPL MTOR CDC20 DOP1A OTOG	3.53e-06	861	164	16	36931259
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TBX3 ATXN7L1 TCP11L1 ESRRA KIAA1549 RREB1 SKI INO80D KIF20A INTS6 ARHGEF40 ZFHX4 UBR5 NFRKB TAF5L TAF4 SLC25A19 BAHCC1	6.03e-06	1116	164	18	31753913
Pubmed	Nuclear Localization of the Autism Candidate Gene Neurobeachin and Functional Interaction with the NOTCH1 Intracellular Domain Indicate a Role in Regulating Transcription.	NBEA NOTCH1	2.21e-05	2	164	2	26999814
Pubmed	Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation.	PCLO BSN	2.21e-05	2	164	2	23403927
Pubmed	Akt-mTOR signaling is involved in Notch-1-mediated glioma cell survival and proliferation.	MTOR NOTCH1	2.21e-05	2	164	2	20372862
Pubmed	Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone.	PCLO BSN	2.21e-05	2	164	2	26793095
Pubmed	MLXIPL promotes the migration, invasion, and glycolysis of hepatocellular carcinoma cells by phosphorylation of mTOR.	MLXIPL MTOR	2.21e-05	2	164	2	36809979
Pubmed	Piccolo and bassoon maintain synaptic vesicle clustering without directly participating in vesicle exocytosis.	PCLO BSN	2.21e-05	2	164	2	20332206
Pubmed	Active zone density is conserved during synaptic growth but impaired in aged mice.	PCLO BSN	2.21e-05	2	164	2	21935939
Pubmed	MondoA Is an Essential Glucose-Responsive Transcription Factor in Human Pancreatic β-Cells.	MLXIP MLXIPL	2.21e-05	2	164	2	29282201
Pubmed	mTOR controls ChREBP transcriptional activity and pancreatic β cell survival under diabetic stress.	MLXIPL MTOR	2.21e-05	2	164	2	28606928
Pubmed	Iodide transporter NIS regulates cancer cell motility and invasiveness by interacting with the Rho guanine nucleotide exchange factor LARG.	ARHGEF12 SLC5A5	2.21e-05	2	164	2	22962269
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	2.21e-05	2	164	2	23544943
Pubmed	Constitutive activation of CaMKKα signaling is sufficient but not necessary for mTORC1 activation and growth in mouse skeletal muscle.	CAMKK1 MTOR	2.21e-05	2	164	2	25159322
Pubmed	Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.	SLC1A5 MTOR	2.21e-05	2	164	2	30272366
Pubmed	Genetic factors contributing to autism spectrum disorder in Williams-Beuren syndrome.	MLXIPL UBR5	2.21e-05	2	164	2	31413120
Pubmed	Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo.	PCLO BSN	2.21e-05	2	164	2	25652077
Pubmed	Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module.	MLXIP MLXIPL	2.21e-05	2	164	2	16644671
Pubmed	MicroRNA-33b regulates hepatocellular carcinoma cell proliferation, apoptosis, and mobility via targeting Fli-1-mediated Notch1 pathway.	FLI1 NOTCH1	2.21e-05	2	164	2	32239672
Pubmed	Molecular and genetic crosstalks between mTOR and ERRα are key determinants of rapamycin-induced nonalcoholic fatty liver.	ESRRA MTOR	2.21e-05	2	164	2	23562079
Pubmed	Contrasting Patterns in the Evolution of Vertebrate MLX Interacting Protein (MLXIP) and MLX Interacting Protein-Like (MLXIPL) Genes.	MLXIP MLXIPL	2.21e-05	2	164	2	26910886
Pubmed	Growth inhibitory effect of rapamycin in Hodgkin-lymphoma cell lines characterized by constitutive NOTCH1 activation.	MTOR NOTCH1	2.21e-05	2	164	2	27473087
Pubmed	Uniform expression of Notch1, suppressor of B-cell-specific gene expression, in plasmablastic lymphoma.	MTOR NOTCH1	2.21e-05	2	164	2	21631271
Pubmed	Notch-1 promotes the malignant progression of osteosarcoma through the activation of cell division cycle 20.	CDC20 NOTCH1	2.21e-05	2	164	2	33411691
Pubmed	Dual-color STED microscopy reveals a sandwich structure of Bassoon and Piccolo in active zones of adult and aged mice.	PCLO BSN	2.21e-05	2	164	2	27321892
Pubmed	Elf4 regulates lysosomal biogenesis and the mTOR pathway to promote clearance of Staphylococcus aureus in macrophages.	MTOR ELF4	2.21e-05	2	164	2	33423322
Pubmed	No symphony without bassoon and piccolo: changes in synaptic active zone proteins in Huntington's disease.	PCLO BSN	2.21e-05	2	164	2	32493491
Pubmed	Iodide Binding in Sodium-Coupled Cotransporters.	SLC5A5 SLC5A8	2.21e-05	2	164	2	29131623
Pubmed	Clinicopathological significance of LAT1 and ASCT2 in patients with surgically resected esophageal squamous cell carcinoma.	SLC1A5 LAT	2.21e-05	2	164	2	26936531
Pubmed	Combinatorial expression patterns of LIM-homeodomain and other regulatory genes parcellate developing thalamus.	MAP2 GBX2 PTPRG	2.84e-05	13	164	3	11306624
Pubmed	O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry.	PCLO EMSY BSN	3.61e-05	14	164	3	16452088
Pubmed	Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.	FLI1 ELF4 ELK3	3.61e-05	14	164	3	14635793
Pubmed	Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library.	RIMBP3 RIMBP3C RIMBP3B	3.61e-05	14	164	3	17662146
Pubmed	Deterministic and stochastic allele specific gene expression in single mouse blastomeres.	MRPS31 TBX3 GBX2 HDAC7 KIF20A SLC7A3 CDYL FGFR2 CDC20 NOTCH1	3.61e-05	424	164	10	21731673
Pubmed	Human transcription factor protein interaction networks.	MRPS31 FLI1 DDX31 ATXN7L1 RREB1 SKI PIAS2 INO80D SLC1A5 EMSY PRDM2 ZNF462 ZFHX4 NFRKB ZSCAN18 ELF4 ELK3 TAF5L TAF4	4.77e-05	1429	164	19	35140242
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	MRPS31 ARHGEF28 YRDC INO80D EMSY SACM1L NBAS MLXIPL INTS6 SLC7A3 TMEM242 UBR5 NFRKB PGLS UNKL MAML2 TAF5L TAF4	5.93e-05	1327	164	18	32694731
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC4	6.61e-05	3	164	2	23053434
Pubmed	NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cells.	MTOR NOTCH1	6.61e-05	3	164	2	24122995
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC16 MUC4	6.61e-05	3	164	2	30236127
Pubmed	MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.	MUC16 MTOR	6.61e-05	3	164	2	26046375
Pubmed	TXNIP induced by MondoA, rather than ChREBP, suppresses cervical cancer cell proliferation, migration and invasion.	MLXIP MLXIPL	6.61e-05	3	164	2	31782782
Pubmed	Cutting edge: Expression of the transcription factor E74-like factor 4 is regulated by the mammalian target of rapamycin pathway in CD8+ T cells.	MTOR ELF4	6.61e-05	3	164	2	20802152
Pubmed	lncRNA BREA2 promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1.	WWP2 NOTCH1	6.61e-05	3	164	2	36795754
Pubmed	Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).	MUC16 MUC4	6.61e-05	3	164	2	27483328
Pubmed	LAT1 is a critical transporter of essential amino acids for immune reactions in activated human T cells.	DDIT3 LAT	6.61e-05	3	164	2	24038088
Pubmed	MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.	MUC16 MUC4	6.61e-05	3	164	2	24204560
Pubmed	Direct recording and molecular identification of the calcium channel of primary cilia.	PKD2L1 PKD1L2	6.61e-05	3	164	2	24336289
Pubmed	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.	MUC16 MUC4	6.61e-05	3	164	2	24939955
Pubmed	FGFR2 promotes breast tumorigenicity through maintenance of breast tumor-initiating cells.	FGFR2 IL2RG	6.61e-05	3	164	2	23300950
Pubmed	Implications for gene therapy-limiting expression of IL-2R gamma c delineate differences in signaling thresholds required for lymphocyte development and maintenance.	LAT IL2RG	6.61e-05	3	164	2	20592278
Pubmed	Homology of pendrin, sodium-iodide symporter and apical iodide transporter.	SLC5A5 SLC5A8	6.61e-05	3	164	2	29772533
Pubmed	Iodide transport and breast cancer.	SLC5A5 SLC5A8	6.61e-05	3	164	2	26285906
Pubmed	Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.	MUC16 MUC4	6.61e-05	3	164	2	17592322
Pubmed	Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.	MUC16 MUC4	6.61e-05	3	164	2	35879412
Pubmed	Oroxylin A induces autophagy in human malignant glioma cells via the mTOR-STAT3-Notch signaling pathway.	MTOR NOTCH1	6.61e-05	3	164	2	25213258
Pubmed	Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	MLXIP UBOX5 SACM1L UBR5 CAMTA1	1.15e-04	100	164	5	10048485
Pubmed	Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation.	SYNRG LAMB3 UBR5 MTOR	1.17e-04	53	164	4	35216969
Pubmed	A committed precursor to innate lymphoid cells.	ZBTB16 IL2RG	1.32e-04	4	164	2	24509713
Pubmed	CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS.	IL2RG NOTCH1	1.32e-04	4	164	2	27698445
Pubmed	PI3K/Akt/mTOR activation by suppression of ELK3 mediates chemosensitivity of MDA-MB-231 cells to doxorubicin by inhibiting autophagy.	MTOR ELK3	1.32e-04	4	164	2	27301639
Pubmed	Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer.	ZBTB16 MTOR	1.32e-04	4	164	2	23798432
Pubmed	Loss of RACK1 promotes glutamine addiction via activating AKT/mTOR/ASCT2 axis to facilitate tumor growth in gastric cancer.	SLC1A5 MTOR	1.32e-04	4	164	2	37578594
Pubmed	Mechanistic target of rapamycin complex 1 is critical for invariant natural killer T-cell development and effector function.	ZBTB16 MTOR	1.32e-04	4	164	2	24516149
Pubmed	Runx3 Mediates Resistance to Intracellular Bacterial Infection by Promoting IL12 Signaling in Group 1 ILC and NCR+ILC3.	ZBTB16 IL2RG	1.32e-04	4	164	2	30258450
Pubmed	Cloning of a novel Olf-1/EBF-like gene, O/E-4, by degenerate oligo-based direct selection.	EBF1 EBF4	1.32e-04	4	164	2	12139918
Pubmed	TRPV4 activation in human corneal epithelial cells promotes membrane mucin production.	MUC16 MUC4	1.32e-04	4	164	2	39024979
Pubmed	FLI-1 functionally interacts with PIASxalpha, a member of the PIAS E3 SUMO ligase family.	FLI1 PIAS2	1.32e-04	4	164	2	16148010
Pubmed	Self-Restrained B Cells Arise following Membrane IgE Expression.	LAT IL2RG	1.32e-04	4	164	2	25683713
Pubmed	Expression of MUK/DLK/ZPK, an activator of the JNK pathway, in the nervous systems of the developing mouse embryo.	MAP2 MAP3K12	1.32e-04	4	164	2	15749080
Pubmed	Tonic LAT-HDAC7 Signals Sustain Nur77 and Irf4 Expression to Tune Naive CD4 T Cells.	HDAC7 LAT	1.32e-04	4	164	2	28538176
Pubmed	EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion.	EMSY IL2RG	1.32e-04	4	164	2	34963055
Pubmed	Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia.	IL2RG NOTCH1	1.32e-04	4	164	2	20823234
Pubmed	ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells.	SLC1A5 MTOR	1.32e-04	4	164	2	17329400
Pubmed	PPARδ promotes tumor progression via activation of Glut1 and SLC1-A5 transcription.	SLC1A5 MTOR	1.32e-04	4	164	2	28419191
Pubmed	HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease.	MTOR NCKAP1L	1.32e-04	4	164	2	32647003
Pubmed	Genetic Labeling of Nuclei-Specific Thalamocortical Neurons Reveals Putative Sensory-Modality Specific Genes.	GBX2 EBF1 ZFHX4	1.70e-04	23	164	3	27655933
Pubmed	Etv transcription factors functionally diverge from their upstream FGF signaling in lens development.	MTOR FGFR2 NOTCH1	1.94e-04	24	164	3	32043969
Pubmed	ETS-dependent regulation of a distal Gata4 cardiac enhancer.	FLI1 ELF4 ELK3	1.94e-04	24	164	3	22056786
Pubmed	Transcription and Signaling Regulators in Developing Neuronal Subtypes of Mouse and Human Enteric Nervous System.	TBX3 EBF1 ZNF462 ZFHX4 FGFR2 NOTCH1 EBF4	1.99e-04	251	164	7	29031500
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	LRRC24 TBC1D5 ARHGEF12 NBEA GDI2 EMSY ZNF462 CNTNAP5 SLC7A3 UBR5 MTOR ZSCAN18 TAF4 BSN	2.02e-04	963	164	14	28671696
Pubmed	Role of ubiquitin-protein ligase UBR5 in the disassembly of mitotic checkpoint complexes.	UBR5 CDC20	2.19e-04	5	164	2	35217622
Pubmed	mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex.	ESRRA MTOR	2.19e-04	5	164	2	18046414
Pubmed	Botch promotes neurogenesis by antagonizing Notch.	FGFR2 NOTCH1	2.19e-04	5	164	2	22445366
Pubmed	The collapsin response mediator protein 1 (CRMP-1) and the promyelocytic leukemia zinc finger protein (PLZF) bind to UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE), the key enzyme of sialic acid biosynthesis.	ZBTB16 KIAA1549	2.19e-04	5	164	2	17118363
Pubmed	Expression patterns of the coe/ebf transcription factor genes during chicken and mouse limb development.	EBF1 EBF4	2.19e-04	5	164	2	15261831
Pubmed	Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation.	MAP2 NOTCH1	2.19e-04	5	164	2	10205173
Pubmed	PLZF expression maps the early stages of ILC1 lineage development.	ZBTB16 IL2RG	2.19e-04	5	164	2	25838284
Pubmed	STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice.	MAP2 MTOR	2.19e-04	5	164	2	20424326
Pubmed	Yeats4 drives ILC lineage commitment via activation of Lmo4 transcription.	ZBTB16 IL2RG	2.19e-04	5	164	2	31434684
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	PIAS2 ZNF462 USP6 INTS6 PTPRG SLC45A3 CDYL ELK3 CAMTA1 MBD5	2.46e-04	536	164	10	15840001
Pubmed	The COPII cargo adapter SEC24C is essential for neuronal homeostasis.	MAP2 DDIT3 HERPUD1	2.47e-04	26	164	3	29939162
Interaction	GSC interactions	FLI1 TBX3 WWP2 RREB1 SKI ZNF462 ZFHX4 BAHCC1	3.75e-07	87	156	8	int:GSC
Interaction	EGR2 interactions	FLI1 WWP2 RREB1 PIAS2 EMSY ZNF462 ZFHX4 NFRKB BAHCC1	7.57e-06	171	156	9	int:EGR2
Cytoband	5q22	FEM1C DMXL1	1.26e-04	5	164	2	5q22
GeneFamily	Solute carriers	SLC24A5 SLC9A9 SLC28A3 SLC10A3 SLC18B1 SLC1A5 SLC5A5 SLC46A3 SLC7A3 SLC45A3 SLC5A8 SLC25A19 SLC14A2	3.84e-07	395	103	13	752
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	PCLO ZC3HC1 BSN	7.77e-05	15	103	3	26
GeneFamily	ETS transcription factor family	FLI1 ELF4 ELK3	5.30e-04	28	103	3	534
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	MAP2 NBEA CMYA5	5.89e-04	29	103	3	396
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	BDP1 KANSL1L ZBTB16 NBEA ARHGAP6 PTPRG MAML2 MBD5 ALPK2	1.50e-06	176	161	9	M39223
Coexpression	GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP	DPYD SLC9A9 ATXN7L1 TBC1D5 WWP2 NBEA MLXIP NBAS MAML2	3.80e-06	197	161	9	M7403
Coexpression	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	FLI1 ZBTB16 ARHGEF12 MAML2	4.95e-06	19	161	4	M13194
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	BDP1 MAP2 PPFIA2 PCLO ARHGEF12 KIAA1549 NBEA EBF1 CSMD3 PIAS2 PRDM2 ZNF462 HIVEP3 TAOK3 RUNDC3A ZFHX4 CAMTA1 BSN DOP1A ZNF697	1.57e-05	1106	161	20	M39071
Coexpression	GSE34515_CD16_POS_MONOCYTE_VS_DC_UP	KANSL1L EBF1 NCMAP SACM1L HIVEP3 NKG7 TAF5L SLC25A19	3.46e-05	200	161	8	M8765
Coexpression	GSE7852_TREG_VS_TCONV_FAT_UP	ATXN7L1 MLXIP FEM1C NCMAP ARHGAP6 ASL SLC25A19 HERPUD1	3.46e-05	200	161	8	M5733
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN	TBX3 DDX31 IMPG1 TCP11L1 ATG2A SKI INO80D DDIT3 RHD ARHGAP6 MLXIPL LAT MTOR ASL ELF4 MUC4 SLC14A2	4.69e-05	909	161	17	M41018
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	KANSL1L DPYD ZBTB16 TBC1D5 HIVEP3 PTPRG MAML2 MBD5 PDZD2	4.97e-08	196	164	9	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	DPYD ARHGEF28 TBC1D5 NBEA INO80D NBAS UBR5 MAML2 MBD5	5.66e-08	199	164	9	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TBX3 MAP2 PCLO NBEA IGSF10 RUNDC3A CNTNAP5 ASL	5.88e-07	192	164	8	fe9297cb65234d9f511bab1a5dbf2679d5a4cd15
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB16 ATXN7L1 TBC1D5 ARHGAP6 PTPRG MAML2 MBD5 PDZD2	5.88e-07	192	164	8	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	KANSL1L DPYD ZBTB16 TBC1D5 PTPRG MAML2 MBD5 PDZD2	7.41e-07	198	164	8	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PITPNM2 TBX3 ZBTB16 ARHGEF28 ARHGEF12 IFI27 ARHGAP6 ELK3	8.00e-07	200	164	8	7034f57e282982c19c13ee8ab78eabaffa069e30
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PITPNM2 FLI1 ARHGEF12 HDAC7 PTPRG UBR5 ELK3 NOTCH1	8.00e-07	200	164	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCLO KIAA1549 MLXIPL MTOR BSN MUC4 DOP1A	3.83e-06	174	164	7	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	INCENP MAP2 EBF1 KIF20A CDC20 DAGLA PCYT1B	3.98e-06	175	164	7	15c69dd5635c9251c535f1e22467712e9667ae92
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ASAH2 WWP2 CAPN6 EBF1 PIAS2 ZFHX4 UBR5	3.98e-06	175	164	7	085cceb1fc2c4ae2f27e85cea5702defecc2cf44
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC24A5 TBX3 MAP2 NBEA RUNDC3A CNTNAP5 DISP3	5.15e-06	182	164	7	be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1
ToppCell	HSPCs-Ery/Mk_prog.\|HSPCs / Lineage and Cell class	KANSL1L HDAC7 LAT SLC45A3 NKG7 IL2RG HERPUD1	5.33e-06	183	164	7	59cfb02143b6b54dfca7560562e064948f0340ca
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPFIA2 PCLO PKD1L2 CSMD3 ZFHX4 DISP3 OTOG	5.53e-06	184	164	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-T_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INCENP ATXN7L1 KIF20A SERPINB1 NKG7 CDC20 BORA	5.53e-06	184	164	7	185b49630da61cbf45c0926d1b992943296d2a54
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPFIA2 PCLO PKD1L2 CSMD3 ZFHX4 DISP3 OTOG	5.53e-06	184	164	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPFIA2 PCLO PKD1L2 CSMD3 ZFHX4 DISP3 OTOG	5.53e-06	184	164	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	severe_influenza-RBC\|World / disease group, cell group and cell class (v2)	ARHGEF12 IFI27 FBXO30 RHD KIF20A RUNDC3A FHDC1	6.15e-06	187	164	7	f846750575f318503d21ade30f5bfd2e1d4c84af
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMB3 SLC28A3 CMYA5 SLC5A5 ZNF462 SERPINB1 TAF5L	6.15e-06	187	164	7	a6a112689d1c9049f57935ad9d2f4955538427de
ToppCell	HSPCs-Ery/Mk_prog.\|World / Lineage and Cell class	KANSL1L TAOK3 LAT SLC45A3 NKG7 IL2RG HERPUD1	6.36e-06	188	164	7	5390089213cd6ee90dcdfd3c3f5b6765376cccf2
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	SYNRG RNF135 MLXIP MFSD14A MFSD14B ELF4 EBF4	6.82e-06	190	164	7	651a1d3ae286e40f9d9f60e438211c6148d24143
ToppCell	Control-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	PITPNM2 TBX3 ZBTB16 KIAA1549 IFI27 ARHGAP6 PTPRG	6.82e-06	190	164	7	7f3f419fffe02934b6f27b697f7a6401072491ed
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells\|World / Lineage, cell class and subclass	ARHGEF12 IFI27 SLC1A5 RHD RUNDC3A FHDC1 CDC20	6.82e-06	190	164	7	6c7e016a9b425ee9418acd4fe96b9779fe7bd39a
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	FLI1 MAP2 WWP2 CAPN6 EBF1 ZFHX4 FGFR2	7.30e-06	192	164	7	d0649410cf5eacdb0c1dce70e37c7473ef5fddfa
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TBX3 MAP2 PCLO NBEA IGSF10 RUNDC3A CNTNAP5	7.55e-06	193	164	7	a189d46c39067b717509cd144e0225cc93d7731d
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	DPYD SLC9A9 ZBTB16 EBF1 ARHGAP6 PTPRG MAML2	8.08e-06	195	164	7	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 TBX3 EBF1 IFI27 HIVEP3 PTPRG ELK3	8.08e-06	195	164	7	23ced69fd904f1d4114b1a7f99f4b5f65ea8824b
ToppCell	10x5'v1-week_12-13-Hematopoietic-MK-early_MK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FLI1 ZBTB16 IGSF10 ARHGAP6 LAT SERPINB1 PCYT1B	8.08e-06	195	164	7	fa5fc6f605deb5cae96eec14ba4000b19f877ba6
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	PITPNM2 FLI1 TBX3 MAP2 KIAA1549 IFI27 ELK3	8.08e-06	195	164	7	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	Bronchus_Control_(B.)\|World / Sample group, Lineage and Cell type	MUC16 LAMB3 NBEA CMYA5 PRDM2 INTS6 MUC4	8.63e-06	197	164	7	b6dff2ee108813e18657e2d8cf850e2423f8c8e9
ToppCell	mLN-T_cell-Th17\|T_cell / Region, Cell class and subclass	ZBTB16 ARHGEF12 SLC1A5 INTS6 ARHGEF40 TACR2 PDZD2	8.92e-06	198	164	7	efdc9515dd9fb20ef9c8ddc106d88cbdde7d6ea2
ToppCell	Biopsy_Other_PF-Immune-Mast_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	KIAA1549 ENTHD1 RHD NBAS ARHGAP6 LAT SLC45A3	8.92e-06	198	164	7	9f015553598d4c6774b2f9759e8c0f0f93e51c67
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLC1A5 FBXO30 RHD EYS RUNDC3A SLC45A3 FHDC1	9.22e-06	199	164	7	565404c155dfac57c020a8f2d09cbf756da20ffd
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLC1A5 FBXO30 RHD EYS RUNDC3A SLC45A3 FHDC1	9.22e-06	199	164	7	6c174dbcc25b980f10a3d1dfe39e613acac73bb6
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLC1A5 FBXO30 RHD EYS RUNDC3A SLC45A3 FHDC1	9.22e-06	199	164	7	284ee9632413f6404fc0b0c7c393ad813db834f2
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGEF28 MUC16 SLC28A3 NBEA SLC5A5 FGFR2 MUC4	9.53e-06	200	164	7	b992eeddee38e6fe3564e9b1850f6b20b89bf47d
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	PITPNM2 FLI1 ARHGEF12 IFI27 HDAC7 PTPRG ELK3	9.53e-06	200	164	7	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	ZNF211 CMYA5 SLC18B1 SLC46A3 TAF5L DAGLA BORA	9.53e-06	200	164	7	0f4b8b0868bda406fe6bf01d1b722510fdfd0168
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PITPNM2 FLI1 ARHGEF12 IFI27 HDAC7 PTPRG ELK3	9.53e-06	200	164	7	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_only / Treatment groups by lineage, cell group, cell type	SLC1A5 FBXO30 RHD RUNDC3A SLC45A3 FHDC1 CDC20	9.53e-06	200	164	7	83c4181c083b364f0d3a89ae7a0504781fa9fa9f
ToppCell	LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega\|LPS_only / Treatment groups by lineage, cell group, cell type	SLC1A5 FBXO30 RHD RUNDC3A SLC45A3 FHDC1 CDC20	9.53e-06	200	164	7	f15baf287ec467664c23faa53fdea45257f7b9d0
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	PITPNM2 FLI1 ARHGEF12 IFI27 HDAC7 PTPRG ELK3	9.53e-06	200	164	7	eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1
ToppCell	LPS_only-Hematopoietic_Erythro-Megakary\|LPS_only / Treatment groups by lineage, cell group, cell type	SLC1A5 FBXO30 RHD RUNDC3A SLC45A3 FHDC1 CDC20	9.53e-06	200	164	7	ce8281c9556a1f64f8ca8a029110077d4ef5b35e
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PITPNM2 FLI1 ARHGEF12 IFI27 HDAC7 PTPRG ELK3	9.53e-06	200	164	7	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Plin3_(Plin3)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PKD2L1 SLC45A3 SERPINB1 MUC4 SMTNL2	1.17e-05	80	164	5	0d5770c81a223148e57d625ac2c2ae69ab55b36e
ToppCell	Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Plin3_(Plin3)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PKD2L1 SLC45A3 SERPINB1 MUC4 SMTNL2	1.17e-05	80	164	5	413796630e7aeff7c68a69dd2d9b8cd8f56163b4
ToppCell	droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB16 CAMKK1 SLC28A3 SLC7A3 SLC45A3 SERPINB1	1.91e-05	149	164	6	defe2e4a2f3118f8b42e99a4f2bf03e54c1b698f
ToppCell	E18.5-samps-Mesenchymal-Pericyte-pericyte_D\|E18.5-samps / Age Group, Lineage, Cell class and subclass	IMPG1 MAP2 YRDC EBF1 CCDC27 SLC5A8	1.91e-05	149	164	6	dcf68eb25733b5db2893728fe4dca5c7267eb58c
ToppCell	Striatum-Macroglia-OLIGODENDROCYTE\|Striatum / BrainAtlas - Mouse McCarroll V32	PKD2L1 SLC45A3 SERPINB1 MUC4 SMTNL2	1.96e-05	89	164	5	ee1dd3571f5914a8274b71f9ca8b36132ae87fe1
ToppCell	facs-Marrow-KLS-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF28 RHD RIMBP3 RUNDC3A FHDC1 PCYT1B	2.66e-05	158	164	6	9fd77ebdd1babf1c85a85d38d9a15858ab08bc84
ToppCell	facs-Marrow-KLS-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF28 RHD RIMBP3 RUNDC3A FHDC1 PCYT1B	2.66e-05	158	164	6	0edd9b005875f9a4f5446f5d5161f8ba63860793
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KCTD8 CMYA5 NCMAP OR51I2 NKG7 SLC14A2	2.76e-05	159	164	6	50d951cf27a571c0c5002003c16fbc370fa17eb1
ToppCell	Dividing_Macrophages-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	ARHGEF28 INCENP SYNPO2L PKD2L1 KIF20A CDC20	3.51e-05	166	164	6	c503036f3c19ef186e1e62c9643c49dea3827f51
ToppCell	5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PPFIA2 TMEM198 PCLO GBX2 EYS RUNDC3A	4.42e-05	173	164	6	9a3500b06d00d1d4ee42910a3a73327b21beab52
ToppCell	10x5'-GI_small-bowel-Mast-Mast_cells\|GI_small-bowel / Manually curated celltypes from each tissue	KIAA1549 ENTHD1 ZNF462 ARHGAP6 SLC45A3 PCYT1B	4.56e-05	174	164	6	05525bf0a2bde2be4f7c147b17a24530ce8819e0
ToppCell	10x5'-GI_small-bowel-Mast\|GI_small-bowel / Manually curated celltypes from each tissue	KIAA1549 ENTHD1 ZNF462 ARHGAP6 SLC45A3 PCYT1B	4.56e-05	174	164	6	e94c980b25edfd0e8598c416828801fcc00e8ead
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Lymphocytic-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAMKK1 RHD LAT SERPINB1 NKG7 IL2RG	4.71e-05	175	164	6	5d9b1d398c1caead7538f19ce1ae207d3e127bfd
ToppCell	droplet-Liver-LIVER-NPC-1m-Endothelial-Hepatocyte_(Pericentral)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C14orf93 SLC18B1 TMCO4 PTPRG ELK3 NOTCH1	4.71e-05	175	164	6	98dc3b6f69a29d587f503898f09912700950e3d9
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Lymphocytic\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAMKK1 RHD LAT SERPINB1 NKG7 IL2RG	4.71e-05	175	164	6	2cd85b619f0d4771064db34959f154de3a40f15b
ToppCell	3'-Adult-Distal_Rectal-Epithelial-Tuft-related-Microfold_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CEACAM7 LAMB3 IFI27 MAML2 IL2RG ALPK2	4.71e-05	175	164	6	8a37b2811f39bb9baa537e8755a29d559eb8185a
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBX2 EBF1 LAT NKG7 MAML2 IL2RG	4.86e-05	176	164	6	e29a13b8152ee84ca82fd1158d96d3f112e3cde3
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBX2 EBF1 LAT NKG7 MAML2 IL2RG	4.86e-05	176	164	6	00510bf8ede0945dfcbd58cc8f34fddf914b6e49
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC9A9 NCMAP HIVEP3 LAT NKG7 IL2RG	4.86e-05	176	164	6	feafc757e7aa4f17128ff34886beb2fd3461c9ea
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCLO EYS RUNDC3A DISP3 SLC5A8 BSN	4.86e-05	176	164	6	2e1003dc373b14d27f0464d980453fdcfc1005f0
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC9A9 ARHGEF28 HDAC7 LAT SLC45A3 NKG7	5.02e-05	177	164	6	9b4c1ca5c6fca9a7a936dad49a04155903ef9c32
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 SLC28A3 NBEA CMYA5 SLC5A8 MUC4	5.34e-05	179	164	6	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	FLI1 MLXIP MFSD14A ELF4 NKG7 EBF4	5.34e-05	179	164	6	10c7d371937d9d93c12c8d3465430ef9e0c2ec81
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLC9A9 MAP2 R3HCC1L EBF4 PCYT1B PDZD2	5.68e-05	181	164	6	274c0b768925cd5804483303f8c5ebd17a534c41
ToppCell	droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IMPG1 INCENP SLC28A3 KIF20A SLC5A8 CDC20	5.68e-05	181	164	6	74311aac2fe27dc02a9be3bc20e0c7ef1c239049
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	MAP2 PPFIA2 EBF1 ARHGAP6 MAML2 PDZD2	5.68e-05	181	164	6	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IMPG1 INCENP SLC28A3 KIF20A SLC5A8 CDC20	5.68e-05	181	164	6	cf13bf7a531a2d40f8d778629cf2431b684f65f3
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Chrm2-Inhibitory_Gad1Gad2_Htr3a.Chrm2_(Interneuron,__(candidate_CGE-derived_10))\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SLC28A3 SLC5A8 SLC14A2 ALPK2	5.78e-05	57	164	4	e61b10212685e5217550db0812141a1f3f6567c8
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Chrm2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SLC28A3 SLC5A8 SLC14A2 ALPK2	5.78e-05	57	164	4	5ae53d915bee8a5fc7936d2a46517da1b6abbf79
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Chrm2-Inhibitory_Gad1Gad2_Htr3a.Chrm2_(Interneuron,__(candidate_CGE-derived_10))-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SLC28A3 SLC5A8 SLC14A2 ALPK2	5.78e-05	57	164	4	f5edb5e8eddc51e0b8040e88baa5d8971871f9ea
ToppCell	wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ARHGEF12 ATG2A SLC1A5 FBXO30 RUNDC3A FHDC1	5.86e-05	182	164	6	0c77ef4556c1d1512ebe9077df858b28f9e38dd5
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	MAP2 PPFIA2 EBF1 ARHGAP6 MAML2 PDZD2	5.86e-05	182	164	6	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	facs-Heart-LV-18m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBX3 DDX31 INCENP ATG2A ELF4 IL2RG	5.86e-05	182	164	6	6dff753d65ba45db81f3cc0c9f59e1779d490955
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ASAH2 ABCC11 CMYA5 SLC5A8 MUC4 EBF4	6.04e-05	183	164	6	2dde2fb48e7d31271c2f6b1dd74b2ab0b2cb520c
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	INCENP NCMAP KIF20A LAT CDC20 PCYT1B	6.22e-05	184	164	6	1edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	KANSL1L KIAA1549 ZNF462 MLXIPL SLC5A8 ALPK2	6.22e-05	184	164	6	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	INCENP NCMAP KIF20A LAT CDC20 PCYT1B	6.22e-05	184	164	6	8578c50eaa8ce1cefc0228185c66c8e25f4bfc32
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 SLC28A3 NBEA CMYA5 SLC5A8 MUC4	6.22e-05	184	164	6	01c19a830348ab0b9c02c1546a439de70ee10f97
ToppCell	PBMC-Severe-Hematopoietic-RBC-RBC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ARHGEF12 IFI27 SLC1A5 RHD RUNDC3A FHDC1	6.41e-05	185	164	6	44ce50cb99df8ffc50eba311adcf688477618659
ToppCell	PBMC-Severe-Hematopoietic-RBC-RBC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARHGEF12 IFI27 SLC1A5 RHD RUNDC3A FHDC1	6.41e-05	185	164	6	17542ccd52a821c9e99b1a7469e80502e764b3fd
ToppCell	PBMC-Severe-Hematopoietic-RBC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARHGEF12 IFI27 SLC1A5 RHD RUNDC3A FHDC1	6.41e-05	185	164	6	d685a5a2e525db2eba449cfa1e5cd54eb36162a8
ToppCell	PBMC-Severe-Hematopoietic-RBC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ARHGEF12 IFI27 SLC1A5 RHD RUNDC3A FHDC1	6.41e-05	185	164	6	5d8d6fd7800f76ee3aa5cef95241d8e6d7e8db04
ToppCell	PBMC-Severe-Hematopoietic-RBC-RBC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ARHGEF12 IFI27 SLC1A5 RHD RUNDC3A FHDC1	6.41e-05	185	164	6	100b5afdf3c6ab07ffc493f7883f5a7b31c59184
ToppCell	COVID-19_Severe-Hematopoietic_R\|COVID-19_Severe / Disease group, lineage and cell class	ARHGEF12 IFI27 SLC1A5 RHD RUNDC3A FHDC1	6.41e-05	185	164	6	30f064ab7c3890e6f419a845276b145112e78f52
ToppCell	PBMC-Severe-Hematopoietic-RBC-RBC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARHGEF12 IFI27 SLC1A5 RHD RUNDC3A FHDC1	6.41e-05	185	164	6	f3b1907c3b6f930bc161f46efce5e143babab507
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PITPNM2 HDAC7 IGSF10 HIVEP3 RUNDC3A ELK3	6.41e-05	185	164	6	bdd2e6cb20294b39a9d856004bf57ba69cf877e2
ToppCell	COVID-19_Severe-Hematopoietic_R-RBC\|COVID-19_Severe / Disease group, lineage and cell class	ARHGEF12 IFI27 SLC1A5 RHD RUNDC3A FHDC1	6.41e-05	185	164	6	3ed6090b822c6d1d400a421236cddc7511743932
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DPYD MAP2 PPFIA2 CAPN6 FGFR2 SMTNL2	6.61e-05	186	164	6	4d68ee3d32f7ef884faf402ef92b31b0eb4656f1
ToppCell	normal_Pleural_Fluid-Myeloid_cells-Alveolar_Mac\|Myeloid_cells / Location, Cell class and cell subclass	KANSL1L C14orf93 PKD2L1 KCTD21 SLC1A5 ZNF697	6.61e-05	186	164	6	701eea0016d69f0f9d29b613948f91239096e6c7
ToppCell	droplet-Tongue-nan-24m-Myeloid\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLI1 LAT NKG7 IL2RG ALPK2 NCKAP1L	6.61e-05	186	164	6	298ea4c7f61df65537dfef171ca81d4e976d89c5
ToppCell	droplet-Tongue-nan-24m-Myeloid-Langerhans_cell\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLI1 LAT NKG7 IL2RG ALPK2 NCKAP1L	6.61e-05	186	164	6	3e16781b9646de971d953da2c49d4210a4c23fe3
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Lymphocytic\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INCENP KIF20A SERPINB1 NKG7 CDC20 BORA	6.80e-05	187	164	6	e53471c3e146a6f54788d81ecc469aba55b051bb
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INCENP KIF20A SERPINB1 NKG7 CDC20 BORA	6.80e-05	187	164	6	3d7d51fbadb20dc884d0b3c0d61b80f022b19d09
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-hematologic-erythrocytic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ARHGEF12 IFI27 SLC1A5 RHD RUNDC3A FHDC1	7.01e-05	188	164	6	3467149de45b47a5015486ef94bec070e9c3ffc2
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ARHGEF12 IFI27 SLC1A5 RHD RUNDC3A FHDC1	7.01e-05	188	164	6	da211e7fb62fff176aa9c39061aef9ab0af6079e
ToppCell	Influenza_Severe-RBC\|World / Disease group and Cell class	ARHGEF12 IFI27 FBXO30 RHD RUNDC3A FHDC1	7.01e-05	188	164	6	f0438e6a77ee1f0456cb65926685266fff470983
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	HDAC7 ZNF462 UBR5 CDYL FGFR2 MAML2	7.01e-05	188	164	6	b070a0667f1ee9b825b267b6c389b7c42fc436f9
Disease	obsolete_red blood cell distribution width	CYP1A1 ZNF211 ZNF280D LRRC24 ASAH2 TBC1D5 PKD2L1 ZC3HC1 SKI TXNDC11 RHD MLXIPL TAOK3 MFSD14B NFRKB CDYL MUC4 DAGLA NOTCH1 BORA	2.77e-05	1347	155	20	EFO_0005192
Disease	lip morphology measurement	SLC24A5 MAP2 SACM1L CNTNAP5 ELF4 FGFR2 MUC4	6.62e-05	189	155	7	EFO_0007845
Disease	age at menarche	DPYD TBC1D5 WWP2 KCTD8 ZC3HC1 SLC28A3 PRDM2 ZNF462 ZFHX4 PTPRG BSN SLC14A2	7.56e-05	594	155	12	EFO_0004703
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	UBR5 MTOR NOTCH1	7.57e-05	16	155	3	C0334634
Disease	vital capacity	CYP1A1 FLI1 ZBTB16 MAP2 WWP2 PCLO POM121L2 SLC28A3 EBF1 RREB1 SKI R3HCC1L ELF4 FGFR2 SLC14A2 DAGLA OTOG PDZD2	9.16e-05	1236	155	18	EFO_0004312
Disease	gestational age	ZBTB16 EBF1 HIVEP3 EYS UBR5 CAMTA1	9.26e-05	138	155	6	EFO_0005112
Disease	Tourette syndrome, schizophrenia	PITPNM2 TBC1D5 ENTHD1	1.09e-04	18	155	3	EFO_0004895, MONDO_0005090
Disease	Mammary Carcinoma, Human	CYP1A1 TBX3 DPYD ESRRA DDIT3 EMSY SLC5A5 MTOR ELK3 FGFR2 NOTCH1	1.10e-04	525	155	11	C4704874
Disease	Mammary Neoplasms, Human	CYP1A1 TBX3 DPYD ESRRA DDIT3 EMSY SLC5A5 MTOR ELK3 FGFR2 NOTCH1	1.10e-04	525	155	11	C1257931
Disease	Mammary Neoplasms	CYP1A1 TBX3 DPYD ESRRA DDIT3 EMSY SLC5A5 MTOR ELK3 FGFR2 NOTCH1	1.14e-04	527	155	11	C1458155
Disease	Breast Carcinoma	CYP1A1 TBX3 DPYD ESRRA DDIT3 EMSY SLC5A5 MTOR ELK3 FGFR2 NOTCH1	1.36e-04	538	155	11	C0678222
Disease	serum alanine aminotransferase measurement, non-alcoholic fatty liver disease	SLC9A9 SLC46A3	1.63e-04	4	155	2	EFO_0003095, EFO_0004735
Disease	level of Phosphatidylcholine (16:1_18:2) in blood serum	PKD2L1 DAGLA HERPUD1	1.76e-04	21	155	3	OBA_2045083
Disease	Malignant neoplasm of breast	CYP1A1 TBX3 DPYD ESRRA FEM1C HDAC7 DDIT3 EMSY RHD SLC5A5 MTOR ASL ELK3 FGFR2 NOTCH1 DOP1A	1.78e-04	1074	155	16	C0006142
Disease	YKL40 measurement, cerebrospinal fluid biomarker measurement	EYS CNTNAP5	2.71e-04	5	155	2	EFO_0004869, EFO_0006794
Disease	migraine disorder, type 2 diabetes mellitus	SLC28A3 EBF1 RREB1 SKI	2.84e-04	60	155	4	MONDO_0005148, MONDO_0005277
Disease	breast carcinoma	CYP1A1 TBX3 ARHGEF28 INCENP TBC1D5 MIER3 ARHGEF12 POM121L2 EBF1 RREB1 GDI2 HIVEP3 FGFR2 SLC14A2 BAHCC1	3.24e-04	1019	155	15	EFO_0000305
Disease	refractive error	FLI1 ENTHD1 NBEA EBF1 ZNF462 HIVEP3 SLC14A2 DAGLA	3.44e-04	326	155	8	MONDO_0004892
Disease	diet measurement	CYP1A1 DPYD MIER3 KCTD8 POM121L2 SLC28A3 EBF1 UBOX5 TMCO4 NBAS MLXIPL TMEM242 CAMTA1 MBD5 DAGLA	4.38e-04	1049	155	15	EFO_0008111
Disease	able to hear with hearing aids	CYP1A1 ARHGEF28	5.66e-04	7	155	2	EFO_0009720
Disease	pentachlorophenol measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022071
Disease	parathion measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022070
Disease	potassium chromate measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022072
Disease	mercuric chloride measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022068
Disease	heptachlor epoxide measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022067
Disease	methoxychlor measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022052
Disease	azinphos methyl measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022055
Disease	aldrin measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022054
Disease	dicofol measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022060
Disease	disulfoton measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022062
Disease	dieldrin measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022061
Disease	endrin measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022064
Disease	endosulfan measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022063
Disease	heptachlor measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022066
Disease	ethion measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022065
Disease	chlorpyrifos measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022057
Disease	cadmium chloride measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022056
Disease	diazinon measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022059
Disease	dibutyl phthalate measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0022058
Disease	environmental exposure measurement	MUC16 EYS CNTNAP5 CDC20	6.02e-04	73	155	4	EFO_0008360
Disease	DDT metabolite measurement	MUC16 EYS CNTNAP5 CDC20	6.33e-04	74	155	4	EFO_0007886
Disease	blood urea nitrogen measurement	CYP1A1 PPFIA2 EBF1 MLXIP RREB1 ZNF462 MLXIPL MBD5 SLC14A2	6.73e-04	452	155	9	EFO_0004741
Disease	body fat distribution	PITPNM2 CYP1A1 WWP2 SLC28A3 EBF1 PTPRG	7.17e-04	202	155	6	EFO_0004341
Disease	sporadic amyotrophic lateral sclerosis, survival time	SLC9A9 CAMTA1	7.52e-04	8	155	2	EFO_0000714, EFO_0001357
Disease	alcohol consumption measurement	CYP1A1 DDX31 ZNF280D PCLO ENTHD1 SLC28A3 NBEA CSMD3 INO80D NBAS MLXIPL CNTNAP5 MTOR CAMTA1 SLC14A2 BAHCC1	8.67e-04	1242	155	16	EFO_0007878
Disease	serum gamma-glutamyl transferase measurement	RNF135 SLC28A3 EBF1 RREB1 SKI CSMD3 EMSY MLXIPL EYS FGFR2 TAF4 ALPK2 BAHCC1	1.11e-03	914	155	13	EFO_0004532
Disease	Odontome	TBX3 FGFR2	1.20e-03	10	155	2	C0524730
Disease	1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement	PKD2L1 HERPUD1	1.20e-03	10	155	2	EFO_0800464
Disease	Tooth Abnormalities	TBX3 FGFR2	1.20e-03	10	155	2	C0040427
Disease	nasopharyngeal neoplasm	PPFIA2 PCLO SLC28A3 EYS R3HCC1L	1.24e-03	151	155	5	EFO_0004252
Disease	autism spectrum disorder (implicated_via_orthology)	SLC9A9 ZNF280D NBEA TAOK3 CNTNAP5	1.28e-03	152	155	5	DOID:0060041 (implicated_via_orthology)
Disease	eye color	SLC24A5 MUC16 HIVEP3 EYS	1.32e-03	90	155	4	EFO_0003949
Disease	biological sex	DDX31 ZNF280D SLC28A3 PIAS2 CNTNAP5 SLC14A2	1.40e-03	230	155	6	PATO_0000047
Disease	eye measurement, sun exposure measurement	HDAC7 SLC1A5	1.46e-03	11	155	2	EFO_0004731, EFO_0010729
Disease	Thyroid carcinoma	PRDM2 SLC5A5 MTOR	1.61e-03	44	155	3	C0549473
Disease	hemoglobin A1 measurement	PKD2L1 EBF1 RREB1 SKI HIVEP3 MLXIPL TAOK3 MFSD14B ELF4	1.78e-03	520	155	9	EFO_0007629
Disease	Alzheimer disease, APOE carrier status	EBF1 ATG2A NBAS NOTCH1	1.80e-03	98	155	4	EFO_0007659, MONDO_0004975
Disease	blood cobalt measurement	MUC16 EYS CNTNAP5 CDC20	2.01e-03	101	155	4	EFO_0007577
Disease	congenital left-sided heart lesions	FLI1 PKD1L2 HIVEP3	2.07e-03	48	155	3	EFO_0005938
Disease	Amyotrophic Lateral Sclerosis, Familial	GBX2 LAT OTOG	2.07e-03	48	155	3	C4551993
Disease	Amyotrophic Lateral Sclerosis, Sporadic	GBX2 LAT OTOG	2.07e-03	48	155	3	C1862941
Disease	omega-6:omega-3 polyunsaturated fatty acid ratio	INCENP MLXIPL DAGLA	2.33e-03	50	155	3	EFO_0010732
Disease	AMYOTROPHIC LATERAL SCLEROSIS 1	GBX2 LAT OTOG	2.33e-03	50	155	3	C1862939
Disease	Tourette syndrome	PITPNM2 MUC16 CSMD3	2.33e-03	50	155	3	EFO_0004895
Disease	level of Phosphatidylcholine (18:1_18:2) in blood serum	DAGLA HERPUD1	2.39e-03	14	155	2	OBA_2045100
Disease	risk-taking behaviour	DPYD MAP2 TBC1D5 RNF135 POM121L2 SLC28A3 EBF1 HIVEP3 CNTNAP5 TMEM242 BAHCC1	2.43e-03	764	155	11	EFO_0008579
Disease	severe acute respiratory syndrome, COVID-19	ARHGEF28 TCP11L1 NCMAP ARHGAP6 EYS MAML2 CAMTA1 PDZD2	2.59e-03	447	155	8	EFO_0000694, MONDO_0100096
Disease	nervous system disorder	DPYD CAMKK1 NOTCH1	2.75e-03	53	155	3	C0027765
Disease	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	ZBTB16 MTOR NOTCH1	2.75e-03	53	155	3	C1961099
Disease	Neoplasm of uncertain or unknown behavior of bladder	MTOR NOTCH1	2.75e-03	15	155	2	C0496930
Disease	Benign neoplasm of bladder	MTOR NOTCH1	2.75e-03	15	155	2	C0154017
Disease	triacylglycerol 52:3 measurement	PKD2L1 MLXIPL	2.75e-03	15	155	2	EFO_0010415
Disease	Carcinoma in situ of bladder	MTOR NOTCH1	2.75e-03	15	155	2	C0154091
Disease	coffee consumption, cups of coffee per day measurement	CYP1A1 MLXIPL	3.13e-03	16	155	2	EFO_0004330, EFO_0006782
Disease	ankle brachial index	NBAS TMEM242	3.13e-03	16	155	2	EFO_0003912
Disease	Benign neoplasm of stomach	UBR5 FGFR2	3.54e-03	17	155	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	UBR5 FGFR2	3.54e-03	17	155	2	C0496905
Disease	Carcinoma in situ of stomach	UBR5 FGFR2	3.54e-03	17	155	2	C0154060
Disease	Limb Deformities, Congenital	TBX3 FGFR2	3.54e-03	17	155	2	C0206762
Disease	low density lipoprotein particle size measurement	PKD2L1 MLXIPL HERPUD1	3.55e-03	58	155	3	EFO_0008593
Disease	Varicose veins	EBF1 CMYA5 RREB1 HDAC7 ARHGAP6	3.60e-03	193	155	5	HP_0002619
Disease	blood nickel measurement	MUC16 EYS CNTNAP5 CDC20	3.75e-03	120	155	4	EFO_0007583
Disease	gout	SLC28A3 MLXIP RREB1 MLXIPL FGFR2	3.84e-03	196	155	5	EFO_0004274
Disease	response to antipsychotic drug	NBEA EYS CNTNAP5	3.91e-03	60	155	3	GO_0097332
Disease	PROSTATE CANCER, HEREDITARY, 1	INCENP EMSY ARHGAP6	3.91e-03	60	155	3	C4722327
Disease	Carcinoma of bladder	MTOR NOTCH1	3.97e-03	18	155	2	C0699885
Disease	level of Phosphatidylcholine (15:0_18:2) in blood serum	DAGLA HERPUD1	3.97e-03	18	155	2	OBA_2045065
Disease	lysophosphatidylcholine measurement	PKD2L1 DAGLA HERPUD1	4.29e-03	62	155	3	EFO_0010224
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC4 NOTCH1	4.69e-03	64	155	3	DOID:4947 (is_marker_for)
Disease	Malignant Neoplasms	DPYD SLC5A5 MTOR NOTCH1	4.72e-03	128	155	4	C0006826
Disease	Craniosynostosis	ZNF462 FGFR2	4.90e-03	20	155	2	C0010278
Disease	neoplasm of mature B-cells	FLI1 SLC14A2	4.90e-03	20	155	2	EFO_0000096
Disease	Stomach Neoplasms	TBX3 DPYD NBAS PTPRG UBR5 FGFR2	4.95e-03	297	155	6	C0038356
Disease	mean arterial pressure	SYNPO2L ARHGEF12 PKD2L1 EBF1 HDAC7 HIVEP3 TAOK3 BAHCC1	5.01e-03	499	155	8	EFO_0006340
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	MAP2 DDIT3 MAML2 PCYT1B	5.12e-03	131	155	4	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	MAP2 DDIT3 MAML2 PCYT1B	5.12e-03	131	155	4	C4552091
Disease	Juvenile arthritis	MAP2 DDIT3 MAML2 PCYT1B	5.12e-03	131	155	4	C3495559
Disease	Juvenile psoriatic arthritis	MAP2 DDIT3 MAML2 PCYT1B	5.12e-03	131	155	4	C3714758

Protein segments in the cluster

Peptide	Gene	Start	Entry
TSSGIPFSFVSMATG	PTPRG	481	P23470
AGMSESSFLSKRPST	ZNF280D	166	Q6N043
SSFMGSFLTSSLGSA	BAHCC1	71	Q9P281
LMQSGSNDFSAVPSL	BDP1	1336	A6H8Y1
TAFGTSSSSATLPLM	SLC1A5	346	Q15758
VLSLTMSPDGATVAS	CDC20	446	Q12834
VSTALLGIMAPSSFT	DISP3	1336	Q9P2K9
KFAFPTTGSSESLSM	CAMTA1	441	Q9Y6Y1
SFAMPGDTLSALQET	ARHGEF40	806	Q8TER5
LTGSFVPDLIVSMSS	CSMD3	621	Q7Z407
MAAPAPGLISVFSSS	PGLS	1	O95336
DGNSVMSPLFTSTFT	ALPK2	881	Q86TB3
FGLASATPATSTSMI	DPYD	546	Q12882
SSAKGFPSFISDMLS	DOP1A	1506	Q5JWR5
ASSPDLSAGTAVSIM	CEACAM7	241	Q14002
MVPNSSFTSLSSAAI	DMXL1	461	Q9Y485
FSMAGLTSSVASALS	ATG2A	366	Q2TAZ0
LSIMDSTFKAPSAVS	ATXN7L1	591	Q9ULK2
LPANSMSSVASGASF	ARHGEF12	661	Q9NZN5
TSEPKDAASLTGFMS	CCDC27	106	Q2M243
SFSKFVGMSADATPL	R3HCC1L	411	Q7Z5L2
TMSSTVTFDTLLAGP	RIMBP3B	1071	A6NNM3
TMSSTVTFDTLLAGP	RIMBP3C	1071	A6NJZ7
TFTLISNGQSMSFSP	CYP1A1	111	P04798
AMDTEFSASSPASLL	INTS6	731	Q9UL03
VLDGEQTSPSFMSTA	HERPUD1	356	Q15011
ASLSLMPSDLSPFTS	KIAA1549	646	Q9HCM3
ELLQSMGSSPSTESF	ARHGEF28	791	Q8N1W1
SPMTASSLLSFAELF	FEM1C	376	Q96JP0
GPSSSLMLDISDLTF	ENTHD1	31	Q8IYW4
LSSTADTPMLAGVSE	FGFR2	451	P21802
SSSLTPMGRDALGSL	FHDC1	721	Q9C0D6
ATPEMDSGLTGATLS	MUC16	26	Q8WXI7
TSVGSTTDLPAMGFL	MUC16	2506	Q8WXI7
STMGDTSVLTSTPAF	MUC16	7801	Q8WXI7
SLSEAMTSFATTGVP	MUC16	10281	Q8WXI7
TGSLMPVTSAALVTF	MUC4	286	Q99102
ATVPTMSAAFPGASL	DAZAP2	56	Q15038
LSAMGFTAAGIASSS	IFI27	51	P40305
STEAEALASSLMGLF	GDI2	121	P50395
KGISFSSLPSTMESD	KANSL1L	11	A0AUZ9
TLLSVPDSTLASMFS	KCTD8	61	Q6ZWB6
LDSSGMLSPVDSLES	NOTCH1	2191	P46531
SPTAMDAIFGSLSDE	MAGEA11	181	P43364
QGFMLSPTASFVDAS	EYS	2066	Q5T1H1
TSLATLTSFPDSMLG	KCTD21	16	Q4G0X4
TEASSSAFRLMPALG	NFRKB	1051	Q6P4R8
AAAATMALAAPSSPT	INCENP	131	Q9NQS7
SLGSDFSLVMESSPG	MTMR14	441	Q8NCE2
FSLVMESSPGATGSF	MTMR14	446	Q8NCE2
ELSSGSGSLLMAEPS	ELF4	616	Q99607
STSLSEAPPFFMASS	IMPG1	441	Q17R60
FMAPEAISDSGQSFS	CAMKK1	316	Q8N5S9
ALSTPGIRDSAFSME	LAT	181	O43561
VQLSDAYSTGSSLMP	ASL	271	P04424
SLAITAIPGEFTTMS	ASAH2	531	Q9NR71
ASPSSASKEIGMPFS	BSN	1361	Q9UPA5
MPDASLTSSVLSGAS	PCLO	2101	Q9Y6V0
PKAASASISSMSEGD	PCYT1B	351	Q9Y5K3
LSFSDVAISMATLPT	OR51I2	66	Q9H344
SMTFLSTVAATGFLP	SLC10A3	286	P09131
MTELDSSSDLISSPG	PDZD2	1226	O15018
PGSLFAALMATATSS	ABCC11	1366	Q96J66
ASSGTIILSPAMQAF	NCKAP1L	801	P55160
SASDTGSGMLFLSNI	LRRC24	321	Q50LG9
MAEASFGSSSPVGSL	MIER3	1	Q7Z3K6
MSGDNSSSLTPGFFI	OR52N2	1	Q8NGI0
SIDGSFAASVSIMGS	PITPNM2	1111	Q9BZ72
SPTQTMAAADGSLFD	DDX31	101	Q9H8H2
LMGSELFVISPASSF	NBAS	161	A2RRP1
MTTATPLGDTTFFSL	NCMAP	1	Q5T1S8
GAVAAMSSITFPAVS	MFSD14A	341	Q96MC6
GSSLRPDAADSATFM	PKD1L2	1081	Q7Z442
SATFMLPAASSLSSL	PKD1L2	1091	Q7Z442
SSPDMLQSEVSFSVG	ARHGAP6	636	O43182
SAGPAFSMANSALST	MAML2	386	Q8IZL2
STLDLTSPMLGVASE	PLEKHG6	391	Q3KR16
SIFGSMLPASASAPV	MLXIP	341	Q9HAP2
TSTLMATLPGGFSAS	GBX2	101	P52951
MASHSGPSTSVLFLF	IL31	1	Q6EBC2
LEDSSSAFISPQGFM	IGSF10	296	Q6WRI0
TSPFMDALTANGTTN	CDYL	286	Q9Y232
SFLNGSTATSPFAIM	EBF4	501	Q9BQW3
LAAASSMSLPAAAPT	EBF4	521	Q9BQW3
SLPMTDFVSGIAFSI	BORA	456	Q6PGQ7
AFTAVLTSPFPASGM	COL8A2	576	P25067
MSFSATILFSPPSGS	C14orf93	1	Q9H972
STASLEKMPAAFSLF	CMYA5	3671	Q8N3K9
SSMPVTSSSFFGAAS	FLI1	406	Q01543
SSSGIFSFSPANMVS	EBF1	536	Q9UH73
MLPNAASISSASPFS	ELK3	226	P41970
MSSSSPDLLSAALGS	MAP3K12	606	Q12852
TTADFFLTTMPTDSL	IL2RG	36	P31785
SAMSAFTASIGDPLN	MBD5	1121	Q9P267
SSGELMDLTPTGLSS	DAGLA	996	Q9Y4D2
TSFSGMGPSAELMAS	INO80D	951	Q53TQ3
MATPGFSCLLLSTSE	MTRNR2L5	1	P0CJ72
ISSADPSGAFRMLST	LAMB3	706	Q13751
MAAESLPFSFGTLSS	DDIT3	1	P35638
GNIFISPFSISSAMA	SERPINB1	26	P30740
ATSMLTGEAGSLPST	EMSY	1176	Q7Z589
ETEGATRSMLSSFLP	HDAC7	121	Q8WUI4
FSLPSAILATSTMVG	FBXO30	461	Q8TB52
PTINGDLVFSFSTSM	CAPN6	141	Q9Y6Q1
PLEQTFATMVSSLGS	SACM1L	316	Q9NTJ5
IPGFSSLSLSDQMSV	ESRRA	246	P11474
PLVSTTAAFAAAISM	NKG7	91	Q16617
SLCALSTSLLGSMFP	SLC7A3	341	Q8WY07
VAAMSSITFPAISAL	MFSD14B	351	Q5SR56
TLFMAGDTAPSEATS	TACR2	356	P21452
SLLSPMAFSSSSDLT	CNTNAP5	36	Q8WYK1
IFSSMDLLSPSGHSD	PPFIA2	631	O75334
SSGDNLEASLPMISF	PRDM2	1086	Q13029
ISSMSSDLPGLDFLS	PIAS2	541	O75928
SLSTATDGLAATPFM	OTOG	1786	Q6ZRI0
TDGLAATPFMSLEST	OTOG	1791	Q6ZRI0
MSFLNGTSLTPASFI	OR52N1	1	Q8NH53
MLGTGPAAATTAATT	MTOR	1	P42345
SFMSTEPLSAEASLS	RUNDC3A	366	Q59EK9
SGSPETSAAAIMLLT	MRPS31	21	Q92665
PSAAAMTSTASIFLS	SYNPO2L	571	Q9H987
LAASGPASTAASMVI	TAF4	361	O00268
LTFSPDSGLIASASM	TAF5L	516	O75529
LVTFSMAAPGISSQA	TCP11L1	351	Q9NUJ3
SMASPKLVTSDTAAG	RNF135	181	Q8IUD6
ASTLGSMPSFTARLT	UBOX5	436	O94941
DGSSLLTTALPSMAA	TBX3	651	O15119
FFGSLMSATDPVTVL	SLC9A9	206	Q8IVB4
LSEAVLPTMTAFASG	TMCO4	76	Q5TGY1
PQSTGSAATMTALAA	SYNRG	646	Q9UMZ2
AAMTASSSILAKAFP	SLC18B1	146	Q6NT16
TMSSTVTFDTLLAGP	RIMBP3	1071	Q9UFD9
GPDAMSELLSTLSSE	NBEA	1696	Q8NFP9
FLSAFAMTLTGPLTT	SLC46A3	11	Q7Z3Q1
PVALSLTASFMSAVT	SLC5A8	56	Q8N695
LTASFMSAVTVLGTP	SLC5A8	61	Q8N695
STSIPGMAFALLASV	SLC26A10	36	Q8NG04
VKLADFGSASMASPA	TAOK3	161	Q9H2K8
SFGVPSSHLLTASVM	SLC28A3	381	Q9HAS3
DISDTLFTMTQSGPS	MLXIPL	251	Q9NP71
LMPSVSSSFLFGSSA	POM121L2	791	Q96KW2
LSSMSSLGGPAAFSA	SKI	26	P12755
ASSEDSLMTSFLPGP	SLC45A3	421	Q96JT2
MTDLDASFGLTSSPI	ZC3HC1	291	Q86WB0
NISAGMLGFPTSATS	ZFHX4	3081	Q86UP3
MASASSSRAGVALPF	WWP2	1	O00308
SVLDGTDPLSMFAAT	VPS35L	71	Q7Z3J2
FGLSAMSPTKAAVDS	ZBTB16	191	Q05516
TATIPSLSAMLGALF	RHD	201	Q02161
MTSSSPAGLEGSDLS	RREB1	1	Q92766
ALPVGLSLSASFMSA	SLC5A5	56	Q92911
SPMFESTAADLGSVV	KIF20A	21	O95235
EFFSTQAMSSLLSSP	HIVEP3	1161	Q5T1R4
MATALRDPASGSVTF	ZNF211	21	Q13398
TTFMAAGSSAPELVT	SLC24A5	111	Q71RS6
RFSGETSAAALSPMS	SMTNL2	206	Q2TAL5
TSAAALSPMSAATLG	SMTNL2	211	Q2TAL5
PSDTGVSFQAISSMA	PKD2L1	141	Q9P0L9
MPSVSKAAAAALSGS	UNKL	1	Q9H9P5
PLASDILTNTSGSMD	MAP2	726	P11137
FPEVDMTSTNFTGLS	TXNDC11	586	Q6PKC3
AMFPGLSESDSISRS	ZNF697	101	Q5TEC3
SSAFSPDGQMLLTGS	WDR38	26	Q5JTN6
MLLGSPAGSSSILSD	ZSCAN18	136	Q8TBC5
SALSQLSFEVGAPMS	ZNF462	1076	Q96JM2
LVFSDPLMGPASASS	TBC1D5	756	Q92609
MATAALPESGSSLAL	TMEM242	66	Q9NWH2
SMSCPILSSALGTIF	SLC14A2	676	Q15849
SPSLLKAALSTGFMF	SLC25A19	286	Q9HC21
DFSSSPSTNGMFTLT	USP6	811	P35125
TGSSLSSFMASPTDA	TMEM198	326	Q66K66
PFTLASTSIDAMQGS	UBR5	1496	O95071
MFEGPLALTSANLSS	YRDC	186	Q86U90
FASTPSDAVLTSFMS	LRRCC1	261	Q9C099